This ADC Therapeutics Analyst Is No Longer Bullish; Here Are Top 2 Downgrades For Monday
Avi Kapoor 4 months ago
NewsDowngradesAnalyst RatingsTrading Ideas
Top Wall Street analysts changed outlook on top names. ADCT downgraded See analysts' views.
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page.
- HC Wainwright & Co. analyst Robert Burns downgraded ADC Therapeutics SA (NYSE:ADCT) from Buy to Neutral. ADC Therapeutics shares closed at $1.0250 on Friday. See how other analysts view this stock.
- Wells Fargo analyst Elyse Greenspan downgraded W. R. Berkley Corporation (NYSE:WRB) from Equal-Weight to Underweight and lowered the price target from $64 to $58. WR Berkley shares closed at $68.57 on Friday. See how other analysts view this stock.
Considering buying ADCT stock? Here’s what analysts think:
Photo via Shutterstock